Acutaas Chemicals Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 50% at ₹2.5/Share	17-Sep-2026	17-Sep-2026
DividendsFinal Dividend of 30% at ₹1.5/Share	18-Sep-2025	18-Sep-2025
Stock Split5:10	25-Apr-2025	25-Apr-2025
DividendsFinal Dividend of 30% at ₹3/Share	13-Sep-2024	13-Sep-2024

Mutual Fund Holder	Aug 26 Shares held	Sep 26 Shares held
Motilal Oswal Flexi Cap Fund - Regular Plan - Growth	10.86 Lac	10.86 Lac no change
SBI Healthcare Opportunities Fund - Regular Plan - IDCW	9.00 Lac	9.00 Lac no change
Kotak Multi Cap Fund - Regular Plan - Growth	8.27 Lac	8.27 Lac no change
Kotak Multi Asset Allocation Fund - Regular Plan - Growth	4.53 Lac	4.53 Lac no change
UTI Small Cap Fund - Regular Plan - Growth	4.01 Lac	4.01 Lac no change

Neha

12 Oct • 1:49 PM · SEBI-Registered Analyst

🔥 2026 ke Smallcap Superstars! 🚀 GROWTH

🔥 2026 ke Smallcap Superstars! 🚀 Kuch Stocks Ne Diya 249% Tak Return! 2026 mein smallcap stocks ne investors ko shandaar returns diye hain! Infrastructure, technology aur manufacturing sectors ke kuch stocks ne zabardast rally dikhayi hai. 📈 📊 Nifty Smallcap 250 ke Top 10 Performers YTD Returns as of 25 September 2026 🥇 #WelspunCorp — +248.8%

WELCORP

🥈 #HFCL — +211.7% 🥉 #AdityaInfotech — +147.4% 🔹 #SyrmaSGSTechnology — +136.4% 🔹 #AtherEnergy — +98.3% 🔹 #FinolexCables — +94.5% 🔹 #AcutaaSChemicals — +91.4% 🔹 #AegisLogistics — +89.1% 🔹 #ACMESolar — +86.1% 🔹 #SAILifeSciences — +75.9% 💡 Lekin ek baat yaad rakhiye! Sirf past returns dekhkar kisi stock mein invest karna sahi strategy nahi hai. Business fundamentals, valuations, earnings growth aur future outlook ko samajhna bhi zaroori hai. Kyunki jo stock past mein multibagger bana hai, zaroori nahi ki woh future mein bhi wahi returns de! ⚠️ 👇 Aap inmein se kaunsa stock hold kar rahe hain? Comment karke bataiye! 📌 Source: TradingView | Nifty Smallcap 250 🚫 Disclaimer: Educational purpose only. Koi buy ya sell recommendation nahi hai. Returns provided data par based hain aur independently verify nahi kiye gaye hain. #SmallcapStocks #MultibaggerStocks #IndianStockMarket #StockMarketIndia #NiftySmallcap250 #Investing #NehaGupta

Pankaj pawar

1 Sep • 12:12 PM · SEBI-Registered Analyst

Acutaas Chemicals Invests ₹200 Cr in Korea Semicon JV

ACUTAAS

:** The company plans to invest around **₹200 crore** in a **Korea-focused semiconductor chemicals joint venture**, combining Acutaas’ manufacturing and supply-chain capabilities in India with Korean semiconductor technology. The JV is targeting a potential **$100 million market opportunity**, with **two materials already qualified** and pilot-line orders currently underway. Commercial scale-up is expected from **FY28**, while the planned manufacturing capacity is designed to expand by nearly **4x** as demand increases. The initiative marks Acutaas Chemicals’ entry into the high-growth semiconductor materials ecosystem and could create a new long-term revenue opportunity as India and global semiconductor supply chains diversify. **Stock Commentary:** **Positive;** the proposed ₹200 crore investment provides Acutaas Chemicals with exposure to the rapidly expanding semiconductor chemicals market. Existing material qualifications and pilot-line orders provide early validation, while the planned 4x capacity scalability offers significant long-term growth potential. Commercial ramp-up from FY28 remains the key monitorable. **Impact:** **Positive**

Neha

21 Aug • 10:19 AM · SEBI-Registered Analyst

Stocks With Strong Future Guidance — Worth Tracking

• V-Marc • RR Kabel • Finolex • HFCL

HFCL

• E2E Networks • MTAR Technologies • Syrma SGS • Netweb Technologies • Sterlite Technologies • Sansera Engineering • Azad Engineering • Omnitech Engineering • Dynamatic Technologies • Aequs • Rossell Techsys • Sona BLW • TD Power Systems • Ramkrishna Forgings • Happy Forgings • Shivalik Bimetal Controls • KSH International • Gland Pharma • Aarti Pharmalabs • Kwality Pharmaceuticals • Sudeep Pharma • Hitachi Energy India • Neogen Chemicals • Quality Power • Ather Energy • Sky Gold • Cupid • Sai Life Sciences • Electronics Mart India • Neuland Laboratories • Shilpa Medicare • Laurus Labs • Shadowfax Technologies • Sedemac Mechatronics • Siemens Energy India • Premier Energies • Navin Fluorine • Mold-Tek Technologies • Muthoot Microfinance • SJS Enterprises • Lloyds Engineering Works • Garware Hi-Tech Films • Universal Cables • Kalyan Jewellers • Bluestone Jewellery • P N Gadgil & Sons • TVS Motor • Bajaj Auto • Paytm • Eternal • IDFC First Bank • PNGS Reva Diamond Jewellery • Craftsman Automation • Apcotex Industries • Timex Group India • Deep Industries • Cholamandalam Investment & Finance • Equitas Small Finance Bank • Acutaas Chemicals • Apar Industries • CreditAccess Grameen • Lodha Developers • Shriram Finance • Sakar Healthcare • Rajratan Global Wire • Fineotex Chemical • Thyrocare Technologies • Ujjivan Small Finance Bank • Emmvee Photovoltaic Power • Gandhar Oil Refinery • NTPC Green Energy • Titan Company • Cyient DLM • Polycab India • Hindusthan Urban Infrastructure • Mahindra & Mahindra Financial Services • Huhtamaki India • Adani Energy Solutions • Dynamic Cables • Beta Drugs • Shyam Metalics & Energy • Anand Rathi Wealth • Prime Cable Industries • Groww • Landmark Cars • ICICI Bank • Bhansali Engineering Polymers • Poonawalla Fincorp • Jayaswal Neco Industries • Tatva Chintan Pharma Chem • Navkar Corporation • Federal Bank • Jio Financial Services • RBL Bank • L&T Finance • V2 Retail • SG Finserve

Stock Reader

19 Aug • 6:43 AM · SEBI-Registered Analyst

Acutaas Chemicals (ACUTAAS) Business & Investment Outlook

ACUTAAS

Acutaas Chemicals delivered strong Q1 FY27 growth, supported by advanced intermediates, improving margins and growing opportunities across pharmaceuticals, semiconductor materials and battery chemicals. Strengths Strong Q1 performance: Revenue increased 59% YoY, EBITDA 122% and PAT 68%. Advanced Intermediates: Revenue grew 77% YoY to around ₹290 crore. Diversified business: Exposure to pharmaceutical intermediates, specialty chemicals and semiconductor materials. Margin expansion: Product mix and operating leverage are supporting profitability. Weaknesses Specialty Chemicals pressure: Revenue declined 11% YoY as the company phases out lower-margin commodity chemicals. Quarterly volatility: Q1 is seasonally weaker, making quarterly comparisons less representative of the full year. Execution requirements: Multiple new businesses require successful commissioning and ramp-up. Opportunities Semiconductor growth: Strong demand from AI and memory chips could support the company's BFC business. Indichem facility: The new manufacturing facility is expected to start contributing from Q1 FY28. Battery chemicals: Trial runs have been completed and the plant is moving toward commissioning. Pharma opportunity: Healthy RFP activity across NCE and API provides potential for future growth. Threats Execution risk in new facilities and product launches. Cyclicality in semiconductor and specialty chemical markets. Customer concentration or project delays could affect growth. Valuation risk: Strong earnings expectations may already be reflected in the stock price. Key Takeaway Acutaas Chemicals is transitioning toward higher-value specialty and advanced chemical products, while expanding into semiconductor and battery chemicals. The key factors to monitor are revenue growth, EBITDA margins, advanced-intermediate demand, Indichem commissioning, battery-chemical ramp-up and cash-flow generation.

Kumar Satyam

18 Aug • 8:37 PM · SEBI-Registered Analyst

Acutaas Chemicals Receives ECMS Approval for Electrolyte Additives

Key Highlights Acutaas Chemicals has received approval under the Electronics Components Manufacturing Scheme (ECMS) for its electrolyte additives business. The approval supports the company's expansion plans, with an expected incentive benefit of up to 25% during FY31. Business Update • Cumulative Investment: ₹256.47 Crore. • Eligible Investment: ₹119.12 Crore. • Expected Incentive Benefit: Up to 25% during FY31. • The approval supports expansion of the company's electrolyte additives business. What It Means • ECMS approval supports the company's investment and expansion plans in electrolyte additives. • The eligible investment of ₹119.12 Crore forms the basis for the expected scheme benefits. • The potential incentive of up to 25% during FY31 could support the economics of the planned investment. • Expansion in electrolyte additives provides an opportunity to increase the company's presence in the electronics components manufacturing ecosystem. Market Impact Impact: Positive The ECMS approval is a positive development for Acutaas Chemicals, as it supports the company's electrolyte additives expansion and provides eligibility for incentives. The potential benefit of up to 25% during FY31 adds to the strategic significance of the approval. Learning Outcome The Electronics Components Manufacturing Scheme (ECMS) is a government framework designed to support domestic manufacturing of electronics components. Incentive schemes can improve the economics of eligible investments and encourage companies to expand local manufacturing capabilities.

ACUTAAS

Ankit Gupta

18 Aug • 1:19 PM · SEBI-Registered Analyst

ACUTAAS

CHEMICALS

ACUTAAS

: APPROVAL RECEIVED UNDER ELECTRONICS COMPONENTS MANUFACTURING SCHEME FOR ELECTROLYTE ADDITIVES BUSINESS; CUMULATIVE INVESTMENT OF ₹256.47 CRORES WITH ELIGIBLE INVESTMENT OF ₹119.12 CRORES; EXPECTED INCENTIVE BENEFIT UP TO 25% DURING FY 2030-31.

Acutaas Chemicals Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Acutaas Chemicals Ltd. 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Acutaas Chemicals Ltd.?

What is the market cap of Acutaas Chemicals Ltd.?

Should I buy Acutaas Chemicals Ltd. stock now?

What is the 52 week high and low of Acutaas Chemicals Ltd.?

Is the Acutaas Chemicals Ltd. stock good to buy?

Is Acutaas Chemicals Ltd. a good buy for the long term?

Is Acutaas Chemicals Ltd. overvalued or undervalued?

What is the PE and PB ratio of Acutaas Chemicals Ltd.?